Development of the cancer therapy satisfaction questionnaire: Item generation and content validity testing

Value in Health

Volumn 8, Issue SUPPL. 1, 2005, Pages

  Abetz, Linda ^a   Coombs, John H ^b   Keininger, Dorothy L ^a   Earle, Christopher C ^c   Wade, Crystal ^a   Bury Maynard, Denise ^b   Copley Merriman, Kati ^b   Hsu, Ming Ann ^b  

^a MAPI VALUES   (United States)

^b PFIZER INC   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cancer; Chemotherapy; Patient outcome assessment; Questionnaire design; Satisfaction

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER THERAPY; COLORECTAL CANCER; CONTENT VALIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXPECTATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; INTRAVENOUS ADMINISTRATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; TREATMENT OUTCOME;

EID: 30944446359     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2005.00073.x     Document Type: Editorial

References (24)

1. Borras JM, Sanchez-Hernandez A, Navarro M, et al. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomized controlled trial. BMJ 2001;322:826-8.
2. Brown R, Dunn S, Butow P. Meeting patient expectations in the cancer consultation. Ann Oncol 1997;8:877-82.
3. Bosnjak S, Radulovic S, Neskovic-Konstantinovic Z, Mitrovic L. Patient statement of satisfaction with antiemetic treatment is related to quality of life. Am J Clin Oncol 2000;23:575-8.
4. McBurney C, Coombs J, Hsu M-A, et al. An appraisal of treatment satisfaction and patient preference assessments in patients diagnosed with cancer. Poster presentation at ISPOR 7th Annual Meeting. Value Health 2002;5:201.
5. Zahnd D, Aebi S, Rusterholz S, et al. A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices. Ann Oncol 1999;10:727-9.
6. Martoni A, Piana E, Strocchi E, et al. Comparative crossover trial of two intravenous doses of granisetron (1 mg vs. 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis. Anticancer Res 1998;18:2799-804.
7. O'Toole D, Ducreux M, Bommelaer G, et al. Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer 2000;88:770-6.
8. Ernst DS, Brasher P, Hagen N, et al. A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain. J Pain Symptom Manage 1997;13:319-26.
9. Bruera E, Neumann CM, Pituskin E, et al. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration. Ann Oncol 1999;10:1255-8.
10. Balmer CE, Thomas P, Osborne RJ. Who wants second-line, palliative chemotherapy? Psychooncology 2001;10:410-18.
11. McQuellon RP, Muss HB, Hoffman SL, et al. Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer. J Clin Oncol 1995;13:858-68.
12. Bremnes RM, Andersen K, Wist EA. Cancer patients, doctors and nurses vary in their willingness to undertake cancer chemotherapy. Eur J Cancer 1995;31A:1955-9.
13. Brundage MD, Feldman-Stewart D, Cosby R, et al. Cancer patients' attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns 2001;45:149-57.
14. Brundage MD, Groome PA, Feldman-Stewart D, et al. Decision analysis in locally advanced non-small-cell lung cancer: is it useful? J Clin Oncol 1997;15:873-83.
15. Grunfeld E, Fitzpatrick R, Mant D, et al. Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 1999;49:705-10.
16. Jansen SJ, Kievit J, Nooij MA, et al. Patients' preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile? Br J Cancer 2001;84:1577-85.
17. Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998;317:771-5.
18. Oliver RL. A cognitive model of the antecedents and consequences of satisfaction decisions. J Marketing Res 1980;17:460-9.
19. Oliver RL. Cognitive, affective, and attribute bases of the satisfaction response. J Consum Res 1993;20:418-30.
20. Oliver RL. Satisfaction: A Behavioral Perspective on the Consumer. New York: McGraw-Hill, 1997.
21. Churchill GA Jr, Surprenant C. An investigation into the determinants of customer satisfaction. J Marketing Res 1982;19:491-504.
22. Woodside AG, Frey LL, Daly RT. Linking service quality, customer satisfaction and behavioral intention. J Health Care Market 1989;9:5-17.
23. Ware JE Jr, Davies AR. Behavioral consequences of consumer dissatisfaction with medical care. Eval Program Plann 1983;6:291-7.
24. Bolton RN, Drew JH. A multistage model of customers' assessments of service quality and value. J Consum Res 1991;17:375-84.